Chronic Idiopathic Constipation
Addressing chronic idiopathic constipation
Chronic idiopathic constipation (CIC) is a common condition in the United States, characterized by persistent and unexplained difficult, infrequent, or incomplete bowel movements. CIC is associated with significantly impaired quality of life, disrupted productivity, and higher healthcare-related costs.
While causes remain unclear, effective management strategies, including lifestyle modification and pharmacologic treatment, can help alleviate symptoms and improve daily functioning.
Facts and Figures
9-20%
CIC affects an estimated 9–20% of U.S. adults.
2x
Women are more than twice as likely as men to have CIC.
↑
Prevalence increases with age.
> 6/10
CIC significantly impacts daily life. Patients report an average daily burden of more than 6 out of 10 when assessing impact of quality of life.
$6,284
Average outpatient cost for CIC patients is an estimated $6,284/year.
Impact
CIC’s negative impact on daily life is comparable to that observed in patients with chronic obstructive pulmonary disorder, diabetes mellitus, or depression.
Patient Advocacy Partners
We’re proud to partner with organizations that raise awareness for those living with CIC and support the patient journey.
Interested in our clinical trials?
Our Mission and Values
Here at Ardelyx, we‘re dedicated to discovering, developing, and commercializing first-in-class targeted medicines that advance patient care.
Commitment to Patients
We believe in working closely with patients and their caregivers, listening to their needs and insights, and setting new standards in product innovation, patient care, and community engagement.
US-COR-0071v5